Exosens Shares Bounce Back 5.05% to €61.35, Second Highest Rise in SBF 120

A Significant Rebound Bringing the Share Closer to Its 20-Day Moving Average

Exosens shares climbed 5.05% to €61.35, marking its best session in several weeks. This rebound partially erases last week’s decline, bringing the seven-day performance back to +5.05%. Year-on-year, the stock still shows a solid gain of +58.12%. Technically, the price is approaching the 20-day moving average (€62.21), remaining slightly below it (-1.38%). The RSI at 40 has moved out of the low zone reached last week, when the stock had entered an oversold state around €57. The 200-day average at €51.60 remains well below the current price, reflecting the underlying bullish trend. In today's rankings, Exosens holds the second position in the SBF 120, behind Atos (+8.41%) and ahead of Exail Technologies (+4.81%).

Tight Valuation at 32 Times Earnings Before May 22 General Meeting

Recent developments are marked by the first quarter results published on April 29, showing a revenue increase of 19.7% to €122.6 million and an adjusted gross margin improvement. Last week, the group also announced the consolidation of its brands Photonis, Xenics, and Telops under the Exosens umbrella. In terms of valuation, the stock is trading at approximately 32.6 times the expected earnings for the current fiscal year and 27.5 times those of the next fiscal year, according to a consensus of eight analysts updated on May 16. The average in the industrial sector is at 17.8 times. Earnings per share growth is expected at +18.4% from one fiscal year to the next. The shareholding structure remains significantly influenced by the presence of company executives and founders, with 31.3% held by insiders and 46.1% by institutional investors. The next key event is scheduled for May 22 with the annual general meeting, followed by the half-year results on July 28.